Crossmark

Primary Peritoneal Hepatoid Adenocarcinoma Patients Treated by Complete Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Crossref DOI link: https://doi.org/10.1007/s13193-023-01737-5

Published Online: 2023-03-29

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Buiron, Charles

Grange, Remi

Rousset, Pascal

Villeneuve, Laurent

Benzerdjeb, Nazim

Glehen, Olivier

Kepenekian, Vahan https://orcid.org/0000-0001-9885-8600
License Information

Text and Data Mining valid from 2023-03-29

Version of Record valid from 2023-03-29
More Information

Article History

Received: 15 February 2023

Accepted: 21 March 2023

First Online: 29 March 2023

Declarations

:

: Olivier Glehen is consultant for GAMIDA. All the other authors (CB, RG, PR, LV, NB, and VK) declare that they have no conflict of interest in line with this publication.

Document is current

Any future updates will be listed below